Navigation Links
Representative Scott Peters Visits Avelas Biosciences

SAN DIEGO, Nov. 20, 2015 /PRNewswire/ -- Today U.S. Congressional Representative (CA-52) Scott Peters toured Avelas Biosciences, a clinical stage oncology-focused company dedicated to improving cancer patient care from diagnosis through treatment. During the visit, he met with local entrepreneurs from Avelas, Avalon Ventures and COI Pharmaceuticals as well as medical innovators from UCSD.

"It was a privilege to host Representative Peters at Avelas Biosciences today," said Carmine Stengone, president and CEO of Avelas Biosciences. "We appreciate all the work he has done to support medical innovation and the opportunity to showcase our disruptive technology designed to improve cancer surgery and therapeutic targeting. Avelas is a true San Diego biotech innovation story, with San Diego technology, investors, entrepreneurs and medical innovators."

Avelas Biosciences was founded by Avalon Ventures on technology from the lab of Nobel laureate Roger Y. Tsien, Ph.D., professor of chemistry, biochemistry and pharmacology at UC San Diego. It is headquartered at COI Pharmaceuticals, Avalon's Community Of Innovation. Avelas is developing AVB-620, a fluorescent, cancer "illuminator" that is designed to enable surgeons to distinguish tumor tissue from normal during surgery. AVB-620 is in clinical trials for breast cancer under the leadership of Anne Wallace, M.D., director of the Comprehensive Breast Health Center at Moores Cancer Center at UC San Diego Health.

"At UC San Diego, we are committed to translating science discovered in the lab to our cancer patients, to providing access to new and often dramatic technologies through early clinical trials," said Dr. Wallace. "This partnership between science, clinicians and the community allows us to help bring forward improvements in cancer care for patients here and around the world."

Representative Peters stated, "Avelas, Avalon and the Community Of Innovation are more examples of San Diego's leadership in the fields of bioscience and biotechnology. The collaborative approach I saw here today is what sets San Diego apart and why the research performed in San Diego is recognized around the world."

Earlier this month, Representative Peters was honored by the Healthcare Leadership Council as a "Champion of Healthcare Innovation" in recognition of his support of patient-centered medical progress.

About Avelas Biosciences
Avelas Biosciences is a San Diego-based biotechnology company focused on developing technologies that advance a new standard-of-care for cancer surgery and therapeutic intervention. Lead candidate AVB-620 is in phase 1b trials in up to 39 breast cancer patients, assessing safety, pharmacokinetics and fluorescence properties using tissue image analysis. Avelas was founded by Avalon Ventures on technology from Nobel laureate Roger Y. Tsien, Ph.D.  For additional information, please visit

University of California Disclaimer
The information stated above was prepared by Avelas Biosciences Inc. and reflects solely the opinion of the corporation. Nothing in this statement shall be construed to imply any support or endorsement of Avelas Biosciences, Inc. or any of its products, by The Regents of the University of California, its officers, agents and employees.


SOURCE Avelas Biosciences
Copyright©2015 PR Newswire.
All rights reserved

Related biology technology :

1. BlueInGreen® Expands into Canada – Signs Representative Agreement with H2Flow Equipment Inc.
2. Alabama Lyme Disease Association Has Representation on Commission Established by the Alabama House of Representatives to Study Lyme Disease and Other Tick-Borne Illnesses
3. The Return of Extinct Animals – and Maybe Humans; Latest Topic by HuffPost Columnist and Sociologist Gini Graham Scott
4. TGen-Scottsdale Healthcare clinical trial results for BIND-014 presented at AACR 2013
5. Scottish Scientists Lead This Years Life Science Discoveries
6. Regenesis Biomedical Names Scott Brooks Chief Executive Officer
7. RRD International Names J. Scott Tarrant President
8. Masy Systems Adds Scott Suttinger as Product Manager of DataTrace Dataloggers and Equipment Rentals
9. Three World-Renowned Philadelphia Scientists Are Named As Recipients Of The 2013 John Scott Award
10. Hart-Scott-Rodino Waiting Period Expires for Shires Acquisition of ViroPharma
11. Dynamic Innovative Technology Showcased at Scottsdale Company’s Open House
Post Your Comments:
(Date:10/3/2019)... ... ... Yesterday, at the 2019 meeting of Outsourcing in Clinical Trials New England in Boston, ... important design factors that currently limit the success of early stage stem cell clinical ... in his talk Dr. Sherley focused on the highly problematic practice of ...
(Date:9/24/2019)... ... September 24, 2019 , ... Personalized Stem ... and site qualification for clinical trial sites and physician investigators. The clinical ... clinical trial participants. , Clinical trial sites are currently located in San Diego ...
(Date:9/17/2019)... , ... September 17, 2019 , ... Tucker, a Labrador ... only four months old, Tucker was limping and lame on his right hip and ... dysplasia and it was called “the worst case the vet had seen.” He was ...
(Date:9/17/2019)... BOSTON (PRWEB) , ... September 16, 2019 , ... ... event was co-located with the China Focus @ Biotech Week Boston, a forum ... investment and collaborations in healthcare innovation. , After a careful process of evaluation, ...
Breaking Biology Technology:
(Date:9/24/2019)... ... September 24, 2019 , ... HT Medical ... porous titanium spinal implants with the expansion of its proprietary Ti3D® spinal interbody ... tripling the number of cervical and lumbar instrumentation sets available for surgical use. ...
(Date:9/22/2019)... ANGELES (PRWEB) , ... September 20, 2019 , ... ... that instrument makers are adjusting to client demands for precision medicine products. The ... with demand exceeding $19 billion in 2018, the pharma/bio sector is the largest ...
(Date:9/17/2019)... ... September 17, 2019 , ... Dual-board certified ... of the Australia Society of Implant Dentistry (ASID) Accreditation Courses. His lecture, “Understanding ... the Surgical Aspects of Modern Implant Dentistry course. Dr. Kim’s expertise comes from ...
Breaking Biology News(10 mins):